ホーム>>Natural Products>>Laminaran

Laminaran

カタログ番号GC39259

ラミナランは β-1-3-グルカンであり、Eisenia Bicyclis 由来の Dectin-1 の典型的なリガンドであり、強力な免疫調節、放射線防護、および抗がん作用があります。ラミナランは β で構成されています。 (1→3)-グルカンと β (1→6)-分岐し、β を切断するラミナリナーゼ (EC 3.2.1.6) などの酵素によって触媒されます。 (1→3) 債券。ラミナランは、癌免疫療法で使用するための有望な免疫刺激分子です。

Products are for research use only. Not for human use. We do not sell to patients.

Laminaran 化学構造

Cas No.: 9008-22-4

サイズ 価格 在庫数 個数
200mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire
100mg
$35.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Laminaran is a neutral water-soluble β-1-3-glucan and a typical ligand for Dectin-1 isolated from the brown alga D. dichotoma, has potent immunomodulating, radioprotective, and anticancer activities[1]. Laminaran is made up of β (1→3)-glucan with β (1→6)-branches and can be catalyzed by enzymes such as laminarinase (EC 3.2.1.6) that breaks the β (1→3) bonds[2]. Laminaran is a promising immune stimulatory molecule for use in cancer immunotherapy[3].

[1]. Malyarenko OS, et al. Laminaran from brown alga Dictyota dichotoma and its sulfated derivative as radioprotectors and radiosensitizers in melanoma therapy.Carbohydr Polym. 2019 Feb 15;206:539-547. [2]. Laminaran [3]. Song K, et al. Laminarin promotes anti-cancer immunity by the maturation of dendritic cells.Oncotarget. 2017 Jun 13;8(24):38554-38567.

レビュー

Review for Laminaran

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Laminaran

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.